www.MarketResearchReports.com Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies Category : Diseases / Healthcare All logos and Images mentioned on this slide belong to their respective owners.
8
Embed
Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies
The value of the solid tumors market in the APAC region amounted to an estimated $1 billion in 2012 and is expected to register a modest Compound Annual Growth Rate (CAGR) of 12.3% to reach $2.3 billion in 2019. For more information visit: http://www.marketresearchreports.com/gbi-research/solid-tumors-market-asia-pacific-2019-new-drug-approvals-and-anticipated-product
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
www.MarketResearchReports.com
Solid Tumors Market in Asia
Pacific to 2019 - New Drug
Approvals and Anticipated
Product Launches to Trigger a Shift
in Treatment Paradigm to
Targeted Therapies
Category : Diseases / Healthcare
All logos and Images mentioned on this slide belong to their respective owners.
The report provides in-depth analysis of four key therapeutic indications within the Asia-Pacific (APAC) solid tumors market – bladder cancer, ovarian cancer, pancreatic cancer and prostate cancer – covering the four countries of Australia, China, India and Japan.
It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these four solid tumor types.
The value of the solid tumors market in the APAC region amounted to an estimated $1 billion in 2012 and is expected to register a modest Compound Annual Growth Rate (CAGR) of 12.3% to reach $2.3 billion in 2019.
A slower growth rate is expected in India (9.7%) and China (5.5%), due primarily to stricter pricing regulations and recent price cuts.
The average cost of treatment for the four Cancer Types mentioned previously is also estimated to grow from $4,001 in 2012 to $6212.5 by 2019, at a CAGR of 6.5%.
The cost of treatment in Australia will be even higher, increasing from $3,703 in 2012 to $7,576 by 2019, at a CAGR of 10.8, driven mainly by better access and speedier launches of new drugs in the country.
1. Solid Tumors Market in Asia Pacific to 2019 - Introduction
2. Therapeutic Landscape to 20193. Marketed Products to 20194. Pipeline Analysis to 20195. Market Forecast to 20196. Deals and Strategic Consolidations to 2019
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.